News

DRUID AI receives Microsoft certification for AI in Healthcare

The company is the first AI solutions provider in healthcare for Central & Eastern Europe, Middle East and Africa LONDON,…

7 months ago

Eden Launches Free Digital Wellness Community, Expanding Access to Personalized Fitness and Lifestyle Support

New Eden member perks include free access to AI-powered workout plans through Aaptiv—no purchase or credit card required. DENVER, June 4,…

7 months ago

Veeva and Sarah Cannon Research Institute Form Strategic Collaboration to Advance Oncology Clinical Trials

Leading oncology research organization adopts Veeva Clinical Platform to enhance study delivery PLEASANTON, Calif. and NASHVILLE, Tenn., June 4, 2025…

7 months ago

Astellas Chooses Veeva Vault CRM as Global Standard

Vault CRM will support Astellas' commercial agility and execution PLEASANTON, Calif., June 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today…

7 months ago

COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS

- Further protection granted in key territory applying to the significant and growing aesthetic and reconstructive markets - REHOVOT, Israel,…

7 months ago

KUBTEC® Celebrates 20 Years of Medical & Scientific Technology Innovation

STRATFORD, Conn., June 4, 2025 /PRNewswire/ -- This week marks a major milestone for KUBTEC®, as the company celebrates its…

7 months ago

DispatchHealth and Medically Home Merger Closes, Creating a National Platform for Complex Care at Home

Merger brings together clinical care, technology, logistics, and scale to simplify how serious health needs are treated where people are…

7 months ago

Research Grid’s artificial intelligence automates a 3-year Queen Mary clinical trial in seconds

A large heart imaging study previously undertaken at Queen Mary University of London (QMUL) and Barts Health NHS Trust tested…

7 months ago

Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma

Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the treatment of pleural mesothelioma Paris,…

7 months ago

HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis

Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration…

7 months ago